SNA-modified antisense oligonucleotides: A new pathway for renal targeting?
Antisense oligonucleotides (ASOs) have emerged as a powerful class of therapeutics capable of suppressing gene expression with remarkable specificity. However, the clinical applications of ASOs have been limited by delivery challenges and toxicities, particularly when repeated or high dosing is requ...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2025-03-01
|
| Serija: | Molecular Therapy: Nucleic Acids |
| Online pristup: | http://www.sciencedirect.com/science/article/pii/S2162253125000307 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|